Directors’ Dealings

Name	Date and Place of Transaction	Type of Transaction	Price per Item	Total Amount/ Currency	Reason for Disclosure Requirement/ Position	Description of Financial Instrument	ISIN
Dr. Melanie Maas-Brunner	12/29/2023 Xetra	Purchase	€48.76	€34,134.94	Board Member	Shares of BASF SE	DE000BASF111
Dr. Dirk Elvermann	07/14/2023¹ Tradegate	Purchase	€45.52	€154,779.00	Board Member	Shares of BASF SE	DE000BASF111
Dr. Kurt Bock	04/28/2023 Xetra	Purchase	€45.88	€124,966.77	Supervisory Board Member	Shares of BASF SE	DE000BASF111
Dame Alison Carnwath	04/28/2023 Xetra	Purchase	€45.88	€49,959.18	Supervisory Board Member	Shares of BASF SE	DE000BASF111
Prof. Dr. Thomas Carell	04/28/2023 Xetra	Purchase	€45.88	€49,959.18	Supervisory Board Member	Shares of BASF SE	DE000BASF111
Liming Chen	04/28/2023 Xetra	Purchase	€45.88	€49,959.18	Supervisory Board Member	Shares of BASF SE	DE000BASF111
Prof. Dr. Stefan Asenkerschbaumer	04/28/2023 Xetra	Purchase	€45.88	€37,480.86	Supervisory Board Member	Shares of BASF SE	DE000BASF111
Alessandra Genco	04/28/2023 Xetra	Purchase	€45.88	€37,480.86	Supervisory Board Member	Shares of BASF SE	DE000BASF111
Dr. Melanie Maas-Brunner	04/28/2023 Off-market	Purchase	€45.63	€36,500.00	Board Member	Shares of BASF SE	DE000BASF111
Dr. Melanie Maas-Brunner	03/02/2023 Xetra	Purchase	€47.79	€57,352.30	Board Member	Shares of BASF SE	DE000BASF111
Dr. Markus Kamieth	02/28/2023 Xetra	Purchase	€48.44	€145,314.90	Board Member	Shares of BASF SE	DE000BASF111
Michael Heinz	02/27/2023 Börse Stuttgart	Purchase	€48.49	€96,970.00	Board Member	Shares of BASF SE	DE000BASF111
¹ As BASF SE disclosed the preliminary figures for Q2 2023 on July 12, 2023 via an ad-hoc release, the closed period for Q2 2023 already ended prematurely on this date.